Related Experiment Videos
Antidiuretic hormone in congestive heart failure
The American Journal of Medicine
|January 1, 1982
Summary
In severe heart failure, high antidiuretic hormone (ADH) levels contribute to hyponatremia. Hemofiltration normalized ADH, suggesting a potential treatment target for dilutional hypo-osmolality in heart failure patients.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Advanced heart failure often presents with severe edema and hyponatremia.
- Antidiuretic hormone (ADH) plays a crucial role in fluid balance and osmolality regulation.
Purpose of the Study:
- To investigate plasma ADH concentrations in relation to hemodynamics and osmolality in patients with severe congestive heart failure.
- To explore the role of osmoregulation and non-osmolar stimuli in hyponatremia associated with heart failure.
Main Methods:
- Studied 20 patients with severe congestive heart failure.
- Measured plasma ADH concentrations, hemodynamics, and plasma osmolality.
- Administered prazosin to assess atrial receptor response and hemofiltration to evaluate volume receptor response.
Main Results:
- One group exhibited inappropriately high ADH levels relative to low plasma osmolality, indicating impaired osmoregulatory control.
- The other group demonstrated a normal relationship between ADH and plasma osmolality.
- Prazosin induced a rise in ADH in the normal regulating group, linked to decreased left atrial pressure.
- Hemofiltration successfully reversed inappropriately high ADH secretion.
Conclusions:
- Inappropriately high ADH secretion, driven by non-osmolar stimuli, likely causes dilutional hypo-osmolality in severe congestive heart failure.
- Hemodynamic and intrarenal factors may also contribute to this mechanism.
- Targeting ADH secretion could be a therapeutic strategy for managing hyponatremia in heart failure.